Table 1. The antitumor effect of the Maytenus compound in vivo.
Groups | H226 | HeLa | |||
---|---|---|---|---|---|
Control | Maytenus compound | Control | Maytenus compound | ||
Body weight (g) beginning | 13.49±0.54 | 13.93±0.56 | 14.85±1.11 | 14.79±1.17 | |
Body weight (g) ending | 14.97±0.81 | 14.01±1.10 | 15.72±1.85 | 14.07±1.38 | |
Tumor volume (cm3) | 4.95±0.95 | 2.81±0.76 | 3.96±0.72 | 2.81±0.84 | |
Tumor weight (mg) | 0.23±0.07 | 0.15±0.04 | 0.54±0.12 | 0.40±0.09 | |
Inhibitory rate (%) | – | 36.06* | – | 26.45* | |
Liver index | 6.12±0.43 | 6.09±0.19 | 6.11±0.32 | 6.54±0.53 | |
Spleen index | 0.59±0.05 | 0.61±0.14 | 0.70±0.15 | 0.70±0.06 | |
Kidney index | 1.52±0.06 | 1.58±0.05 | 1.53±0.11 | 1.65±0.28 |
The Organ Index was calculated according to formula: Organ weight/Body weight × 100%. *, P<0.05.